UNB Q2 2025 Earnings Solid EPS Performance Amidst Quiet Quarter Marker Therapeutics Inc MRKR Q1 2026 Earnings EPS Beat Expectations Amid Development Stage Operations United Homes Group Q4 2025 Earnings Modest Profitability Achieved Amid Quiet Market Reception BGC Q1 2026 Earnings Slight EPS Miss Triggers Modest SellOff PERF Q1 2026 Earnings Earnings Beat Estimates Amid Strong Operational Execution Viridian Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Thyroid Eye Disease Pipeline